Bookmark

Add to MyYahoo RSS

Opko Health News

News on Opko Health (Ticker: OPK) continually updated from thousands of sources around the net.

22 hrs ago | AmericanBankingNews.com

Opko Health CEO Phillip Md Et Al Frost Purchases 11,400 Shares

Opko Health CEO Phillip Md Et Al Frost acquired 11,400 shares of Opko Health stock on the open market in a transaction that occurred on Friday, August 15th.

Comment?

Related Topix: Biotech

Sun Aug 17, 2014

AmericanBankingNews.com

Opko Health CEO Purchases $174,472 in Stock

Opko Health CEO Phillip Md Et Al Frost acquired 19,300 shares of the company's stock in a transaction dated Thursday, August 14th.

Comment?

Related Topix: Biotech

Fri Aug 15, 2014

AmericanBankingNews.com

Insider Buying: Opko Health CEO Purchases 19,300 Shares of Stock

Opko Health CEO Phillip Md Et Al Frost acquired 19,300 shares of the stock in a transaction that occurred on Thursday, August 14th.

Comment?

Related Topix: Biotech

Tue Aug 12, 2014

Seeking Alpha

OPKO Health's (OPK) CEO Phillip Frost on Q2 2014 Results - Earnings Call Transcript

Greetings and welcome to the OPKO Health Top-Line Rayaldee Results and Second Quarter 2014 Financial Results Conference Call.

Comment?

Related Topix: Biotech, Endocrinology, Medicine

AmericanBankingNews.com

Opko Health Sees Strong Trading Volume Following Better-Than-Expected Earnings

Shares of Opko Health saw unusually-high trading volume on Tuesday following a better than expected earnings announcement, Analyst Ratings News reports.

Comment?

Related Topix: Biotech

Mon Aug 11, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

This trial is one of two identical randomized, double... )--Enterprise Products Partners L.P. today announced that W. Randall Fowler, executive vice president and chief financial officer of Enterprise's general partner, ... )--AVEO Oncology today reported its second quarter 2014 financial results and provided an update on its progress toward ... (more)

Comment?

Related Topix: Biotech, Enterprises Products Partners LP, Energy, Oil & Gas, CVG, Computers, Advertising, Apparel, Nike, Footwear, Real Estate, Kimco Realty

Freshnews

OPKO Announces Second Quarter Operating and Financial Results

OPKO Health, Inc. , a multi-national biopharmaceutical and diagnostics company, today reported operating and financial results for its second quarter ended June 30, 2014.

Comment?

Related Topix: Biotech, Food and Drug Administration, Hemophilia, Health, Medicine, Urology, Prostate Cancer

Thu Aug 07, 2014

Business Wire

OPKO Submits IND for Rayaldeea as Adjunctive Cancer Therapy

The initial investigation described in this IND is a phase 1 dose titration study designed to evaluate the safety and tolerability of Rayaldee in patients with breast or prostate cancer that has metastasized to bone who are receiving treatment with zoledronic acid or denosumab .

Comment?

Related Topix: Biotech, Food and Drug Administration, Prostate Cancer, Health, Vitamin D, Supplement

Freshnews

OPKO to Announce Top Line RAYALDEE Results and Second Quarter 2014...

OPKO Health, Inc. will announce top line data from the first of two identical pivotal Phase 3 clinical trials for RAYALDEE and its second-quarter 2014 financial results on Monday, August 11, 2014, after the market closes.

Comment?

Related Topix: Biotech

Wed Aug 06, 2014

Business Journal

Frost Museum of Science construction on schedule

A $35 million donation by the couple launched construction of the museum, which is targeted to open in 2016.

Comment?

Related Topix: Biotech

Mon Aug 04, 2014

AmericanBankingNews.com

Opko Health CEO Acquires $216,750 in Stock

Opko Health CEO Phillip Md Et Al Frost bought 25,000 shares of Opko Health stock on the open market in a transaction dated Friday, August 1st.

Comment?

Related Topix: Biotech

Mon Jul 28, 2014

AmericanBankingNews.com

Opko Health CEO Phillip Md Et Al Frost Buys 36,000 Shares

Opko Health CEO Phillip Md Et Al Frost bought 36,000 shares of Opko Health stock on the open market in a transaction that occurred on Friday, July 25th.

Comment?

Related Topix: Biotech

GuruFocus.com

Weekly CEO Buys Highlight: OPK, LJPC, SFNC, HAFC, TUBE

According to GuruFocus Insider Data , these are the largest CEO buys during the past week.

Comment?

Related Topix: Biotech, Soros Fund Management, Financial Services, Investment Services, Gabelli Asset Management, La Jolla Pharmaceutical, Medicine, Healthcare Industry, Banking, Simmons First National, Financial Markets

Wed Jul 23, 2014

AmericanBankingNews.com

Opko Health Stock Price Up 3.7% After Insider Buying Activity

Shares of Opko Health rose 3.7% on Wednesday after an insider bought additional shares in the company, Stock Ratings Network reports.

Comment?

Related Topix: Biotech

Tue Jul 22, 2014

BioSpace

Opko Health, Inc. Granted Patent From U.S. Patent & Trademark Office For RAYALDEE

OPKO Health, Inc. , a multinational biopharmaceutical and diagnostics company, today announced that the United States Patent and Trademark Office granted OPKO a patent covering RAYALDEEa , the Company's product to treat secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease and vitamin D insufficiency.

Comment?

Related Topix: Patent / Trademark Law, Biotech

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••